Cyclophosphamide Anhydrous

CHEMBL88 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

261.1 g/mol

LogP

0.6

Phase

4

An anhydrous form of cyclophosphamide, a chemotherapy drug used to treat various cancers and autoimmune diseases. It works by interfering with DNA in rapidly dividing cells to stop their growth.

Peso Molecular

261,0800 g/mol

LogP

0,60

TPSA

41,60 Å²

Regra dos 5 de Lipinski

Aprovado

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

O=P1(N(CCCl)CCCl)NCCCO1

InChI

InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)

Molecular Formula

C7H15Cl2N2O2P

HBD / HBA

1 / 4

Ligações Rotacionáveis

5

Átomos Pesados

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

An anhydrous form of cyclophosphamide, a chemotherapy drug used to treat various cancers and autoimmune diseases. It works by interfering with DNA in rapidly dividing cells to stop their growth.

Yes, Cyclophosphamide Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL88. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 2907. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Procura informações acessíveis para o paciente?

Cyclophosphamide Anhydrous no PillFYI

Estrutura

Dados Rápidos

Fórmula: C7H15Cl2N2O2P

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.